AperionDx develops diagnostic tools for protein detection using a method called Protein-PCR.
AperionDx has raised $1.3M in total funding. The most recent round was Grant. The last funding was announced in January 2024.
AperionDx is headquartered in Carlsbad, United States.
AperionDx develops diagnostic tools for protein detection using a method called Protein-PCR.
AperionDx is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"AperionDx — Funding & Investors." VCBacked, January 1, 2024, https://www.vcbacked.co/company/aperiondx. Accessed August 15, 2026.
VCBacked. (2024). AperionDx — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/aperiondx
{{cite web |title=AperionDx — Funding & Investors |url=https://www.vcbacked.co/company/aperiondx |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated